{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:05Z","timestamp":1792783145622,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H1029"],"award-info":[{"award-number":["20H1029"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grant-in-Aid from the Japan Research Foundation for Clinical Pharmacology","id":[{"id":"https:\/\/ror.org\/01t7fx814","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Oita University","id":[{"id":"https:\/\/ror.org\/01nyv7k26","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11095-026-04145-w","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:06:22Z","timestamp":1782929182000},"page":"2721-2732","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-7971","authenticated-orcid":false,"given":"Ryota","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayato","family":"Sawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erino","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Tatsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"6","key":"4145_CR1","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/cid\/ciaa303","volume":"71","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2020;71(6):1361\u20134.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4145_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030489","volume":"14","author":"K Matsumoto","year":"2022","unstructured":"Matsumoto K, Oda K, Shoji K, Hanai Y, Takahashi Y, Fujii S, et al. Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Pharmaceutics. 2022;14(3):489.","journal-title":"Pharmaceutics"},{"issue":"4","key":"4145_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s11899-013-0171-4","volume":"8","author":"MK Keng","year":"2013","unstructured":"Keng MK, Sekeres MA. Febrile neutropenia in hematologic malignancies. Curr Hematol Malig Rep. 2013;8(4):370\u20138.","journal-title":"Curr Hematol Malig Rep"},{"issue":"6","key":"4145_CR4","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/FTD.0000000000000346","volume":"38","author":"K Hirai","year":"2016","unstructured":"Hirai K, Ishii H, Shimoshikiryo T, Shimomura T, Tsuji D, Inoue K, et al. Augmented renal clearance in patients with febrile neutropenia is associated with increased risk for subtherapeutic concentrations of vancomycin. Ther Drug Monit. 2016;38(6):706\u201310.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"4145_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/FTD.0000000000000978","volume":"44","author":"E Amano","year":"2022","unstructured":"Amano E, Tanaka R, Ono H, Tatsuta R, Hashimoto T, Hiramatsu K, et al. Association of vancomycin trough concentration and clearance with febrile neutropenia in pediatric patients. Ther Drug Monit. 2022;44(4):543\u201351.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"4145_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/11318140-000000000-00000","volume":"49","author":"AA Udy","year":"2010","unstructured":"Udy AA, Roberts JA, Boots RJ, Paterson DL, Lipman J. Augmented renal clearance. Clin Pharmacokinet. 2010;49(1):1\u201316.","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"4145_CR7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s40262-018-0636-7","volume":"57","author":"I Bilbao-Meseguer","year":"2018","unstructured":"Bilbao-Meseguer I, Rodr\u00edguez-Gasc\u00f3n A, Barrasa H, Isla A, Solin\u00eds M. Augmented renal clearance in critically ill patients: a systematic review. Clin Pharmacokinet. 2018;57(9):1107\u201321.","journal-title":"Clin Pharmacokinet"},{"key":"4145_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.723731","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo Y, Wang Y, Ma Y, Wang P, Zhong J, Chu Y. Augmented renal clearance: what have we known and what will we do? Front Pharmacol. 2021;12:723731.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4145_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40560-019-0408-y","volume":"7","author":"KA Morbitzer","year":"2019","unstructured":"Morbitzer KA, Rhoney DH, Dehne KA, Jordan JD. Enhanced renal clearance and impact on vancomycin pharmacokinetic parameters in patients with hemorrhagic stroke. J Intensive Care. 2019;7:51.","journal-title":"J Intensive Care"},{"issue":"1","key":"4145_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12883-020-01771-8","volume":"20","author":"A Lannou","year":"2020","unstructured":"Lannou A, Carrie C, Rubin S, Cane G, Cottenceau V, Petit L, et al. Salt wasting syndrome in brain trauma patients: a pathophysiologic approach using sodium balance and urinary biochemical analysis. BMC Neurol. 2020;20(1):190.","journal-title":"BMC Neurol"},{"issue":"5","key":"4145_CR11","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/jcpt.13193","volume":"45","author":"K Saito","year":"2020","unstructured":"Saito K, Kamio S, Ito K, Suzuki N, Abe K, Goto T. A simple scoring method to predict augmented renal clearance in haematologic malignancies. J Clin Pharm Ther. 2020;45(5):1120\u20136.","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"4145_CR12","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1093\/jac\/dkaf378","volume":"80","author":"J Lipman","year":"2025","unstructured":"Lipman J, Lewis RE. The long walk to a short half-life: the discovery of augmented renal clearance and its impact on antibiotic dosing. J Antimicrob Chemother. 2025;80(12):3367\u201374.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"4145_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrneph.2011.92","volume":"7","author":"AA Udy","year":"2011","unstructured":"Udy AA, Roberts JA, Lipman J. Implications of augmented renal clearance in critically ill patients. Nat Rev Nephrol. 2011;7(9):539\u201343.","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"4145_CR14","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1093\/jac\/dkab302","volume":"76","author":"Y Shimamoto","year":"2021","unstructured":"Shimamoto Y, Verstegen RHJ, Mizuno T, Schechter T, Allen U, Ito S. Population pharmacokinetics of vancomycin in paediatric patients with febrile neutropenia and augmented renal clearance: development of new dosing recommendations. J Antimicrob Chemother. 2021;76(11):2932\u201340.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"4145_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14060570","volume":"14","author":"Y Takumi","year":"2025","unstructured":"Takumi Y, Tanaka R, Iwao M, Tatsuta R, Itoh H. Impact of recovery from febrile neutropenia on intra-individual variability in vancomycin pharmacokinetics in pediatric patients. Antibiotics (Basel). 2025;14(6):570.","journal-title":"Antibiotics (Basel)"},{"key":"4145_CR16","unstructured":"Japanese Society of Medical Oncology. Clinical Practice Guidelines for Febrile Neutropenia (FN), 2nd ed.; Kanehara & Co., Ltd.: Tokyo, Japan, 2017; pp. 2\u20133.; 2017."},{"issue":"3","key":"4145_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/FTD.0000000000001320","volume":"47","author":"N Kondo","year":"2025","unstructured":"Kondo N, Tanaka R, Tatsuta R, Tsushita H, Hashimoto T, Hiramatsu K, et al. Effect of augmented renal clearance and febrile neutropenia on initial trough level and clearance of teicoplanin. Ther Drug Monit. 2025;47(3):385\u201392.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"4145_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629\u201337.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4145_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/cpt.1991","volume":"109","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Sherwin CM, Gonzalez D, Zhang Q, Khurana M, Fisher J, et al. Creatinine-based renal function assessment in pediatric drug development: an analysis using clinical data for renally eliminated drugs. Clin Pharmacol Ther. 2021;109(1):263\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"4145_CR20","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1097\/INF.0b013e318286378e","volume":"32","author":"J Le","year":"2013","unstructured":"Le J, Bradley JS, Murray W, Romanowski GL, Tran TT, Nguyen N, et al. Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J. 2013;32(4):e155-63.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"4145_CR21","doi-asserted-by":"publisher","first-page":"e00067","DOI":"10.1128\/AAC.00067-19","volume":"63","author":"F Kloprogge","year":"2019","unstructured":"Kloprogge F, Hill LF, Booth J, Klein N, Irwin AD, Dixon G, et al. Revising pediatric vancomycin dosing accounting for nephrotoxicity in a pharmacokinetic-pharmacodynamic model. Antimicrob Agents Chemother. 2019;63(5):e00067-e119.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4145_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2133\/dmpk.24.25","volume":"24","author":"BJ Anderson","year":"2009","unstructured":"Anderson BJ, Holford NH. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet. 2009;24(1):25\u201336.","journal-title":"Drug Metab Pharmacokinet"},{"key":"4145_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev.pharmtox.48.113006.094708","volume":"48","author":"BJ Anderson","year":"2008","unstructured":"Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol. 2008;48:303\u201332.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"4145_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00467-008-0997-5","volume":"24","author":"MM Rhodin","year":"2009","unstructured":"Rhodin MM, Anderson BJ, Peters AM, Coulthard MG, Wilkins B, Cole M, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol. 2009;24(1):67\u201376.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"4145_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/psp4.12924","volume":"12","author":"CJ O\u2019Hanlon","year":"2023","unstructured":"O\u2019Hanlon CJ, Holford N, Sumpter A, Al-Sallami HS. Consistent methods for fat-free mass, creatinine clearance, and glomerular filtration rate to describe renal function from neonates to adults. CPT Pharmacomet Syst Pharmacol. 2023;12(3):401\u201312.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"1","key":"4145_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.70097","volume":"66","author":"R Morales Junior","year":"2026","unstructured":"Morales Junior R, Mizuno T, Tan WR, Irie K, Tang Girdwood S. From PICU to NICU: extrapolating meropenem exposure from pediatric to neonatal intensive care patients. J Clin Pharmacol. 2026;66(1):e70097.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"4145_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011;13(2):143\u201351.","journal-title":"AAPS J"},{"issue":"2","key":"4145_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1297\/cpe.25.71","volume":"25","author":"T Isojima","year":"2000","unstructured":"Isojima T, Kato N, Ito Y, Kanzaki S, Murata M. Growth standard charts for Japanese children with mean and standard deviation (SD) values based on the year 2000 national survey. Clin Pediatr Endocrinol. 2000;25(2):71\u20136.","journal-title":"Clin Pediatr Endocrinol"},{"issue":"1","key":"4145_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40262-021-01050-w","volume":"61","author":"A Aljutayli","year":"2022","unstructured":"Aljutayli A, El-Haffaf I, Marsot A, Nekka F. An update on population pharmacokinetic analyses of vancomycin, part II: in pediatric patients. Clin Pharmacokinet. 2022;61(1):47\u201370.","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"4145_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaf087","volume":"14","author":"K Oda","year":"2025","unstructured":"Oda K, Shoji K, Matsumoto K, Kawamura H, Takesue Y, Shigemi A, et al. Development of vancomycin population pharmacokinetic models for pediatric patients using a real-world web application database. J Pediatric Infect Dis Soc. 2025;14(10):piaf087.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"8","key":"4145_CR31","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s40262-021-01027-9","volume":"60","author":"E Chung","year":"2021","unstructured":"Chung E, Sen J, Patel P, Seto W. Population pharmacokinetic models of vancomycin in paediatric patients: a systematic review. Clin Pharmacokinet. 2021;60(8):985\u20131001.","journal-title":"Clin Pharmacokinet"},{"key":"4145_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.713588","volume":"9","author":"DY Li","year":"2021","unstructured":"Li DY, Li L, Li GZ, Hu YH, Guo HL, Jing X, et al. Population pharmacokinetics modeling of vancomycin among Chinese infants with normal and augmented renal function. Front Pediatr. 2021;9:713588.","journal-title":"Front Pediatr"},{"issue":"6","key":"4145_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.ajkd.2025.03.014","volume":"85","author":"AM O\u2019Hare","year":"2025","unstructured":"O\u2019Hare AM, Al-Aly Z. Variability in estimated GFR: when the signal is the noise. Am J Kidney Dis. 2025;85(6):676\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"4145_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121935","volume":"11","author":"KEM Hellenthal","year":"2022","unstructured":"Hellenthal KEM, Brabenec L, Wagner NM. Regulation and dysregulation of endothelial permeability during systemic inflammation. Cells. 2022;11(12):1935.","journal-title":"Cells"},{"issue":"1","key":"4145_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/00003088-199529010-00003","volume":"29","author":"U Jaehde","year":"1995","unstructured":"Jaehde U, S\u00f6rgel F. Clinical pharmacokinetics in patients with burns. Clin Pharmacokinet. 1995;29(1):15\u201328.","journal-title":"Clin Pharmacokinet"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04145-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04145-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04145-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:47:47Z","timestamp":1790005667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04145-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4145"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04145-w","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of the Oita University Faculty of Medicine (Review reference number: 1988). Given the retrospective design of the study, informed consent was obtained through an opt\u2011out process posted on the Department of Clinical Pharmacy website at Oita University Hospital.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}